Slingshot members are tracking this event:
Gelesis (PTCHF) Announces Safety Data from First-In-Human Study Evaluating Gelesis200 in Weight Loss and Improved Glycemic Control in Patients with Type 2 Diabetes
- Source Link:
Slingshot Insights Explained
May 03, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Safety Data, First-in-human Study, Gelesis200, Weight Loss, Improved Glycemic Control, Type 2 Diabetes